Arteris appoints Saurabh Sinha as new CFO
Arteris, Inc. appointed Saurabh Sinha as Chief Financial Officer, effective September 8, 2026.
Rhea-AI Filing Summary
Arteris, Inc. appointed Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. He will also serve as principal financial and accounting officer, succeeding Nick Hawkins, who is retiring after seven years and will support the transition in an advisory role.
Under a July 16, 2026 offer letter, Sinha will receive a $440,000 annual base salary and a target bonus equal to 60% of base salary. As inducement equity, he will receive performance stock units with a target value of $1,000,000, vesting only if Arteris reaches $200,000,000 in trailing four-quarter revenue by December 31, 2030 and a $65 average share price over 15 trading days by December 31, 2031, plus Restricted Stock Units valued at $3,700,000 vesting over four years. A further $1,000,000 PSU award is planned under the 2027 Long-Term Incentive Program, with share counts based on the 30-day trailing average stock price.
Positive
- None.
Negative
- None.
Filing Explained
Arteris’s CFO transition starts September 8; equity awards are not yet granted, and the outgoing CFO is slated to advise through February 2027.
The offer letter says the 2026 PSU and RSU are intended to be granted effective
The press release states that Nick Hawkins will continue as an executive advisor through
8-K Event Classification
Key Figures
Key Terms
performance stock units financial
Restricted Stock Units financial
Long-Term Incentive Program financial
Change in Control Severance Agreement financial
Indemnification Agreement financial
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What leadership change did Arteris (AIP) announce in this report?
What is Saurabh Sinha’s compensation package as Arteris (AIP) CFO?
What performance goals apply to the 2026 PSU grant at Arteris (AIP)?
How will the RSU grant to Saurabh Sinha at Arteris (AIP) vest?
What is the planned 2027 PSU award under Arteris (AIP)’s LTIP?
What prior experience does new CFO Saurabh Sinha bring to Arteris (AIP)?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported):
(Exact name of Registrant, as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
| (Address of principal executive offices, including Zip code) |
Registrant’s telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 5.02 | Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On August 3, 2026, the Board of Directors (the “Board”) of Arteris, Inc. (the “Company”) appointed Saurabh Sinha as the Company’s Chief Financial Officer, effective as of September 8, 2026 (the “Start Date”). Mr. Sinha will also serve as the Company’s principal financial officer and principal accounting officer. Prior to this appointment, Mr. Sinha had served as Aeva Technologies, Inc.’s Chief Financial Officer since September 2020. Prior to joining Aeva, Mr. Sinha was the Chief Accounting Officer of JUUL Labs from July 2018 to August 2020 and served as its interim Chief Financial Officer from January 2020 to May 2020. Prior to joining JUUL Labs, Mr. Sinha held various finance leadership roles, from March 2014 to June 2018, at InvenSense Inc., a motion sensors company. Mr. Sinha received his Bachelor of Commerce degree from the University of Delhi, India and his Master of Business Administration from The Wharton School of the University of Pennsylvania.
The Company entered into an offer letter with Mr. Sinha dated July 16, 2026 (the “Offer Letter”) which provides that, among other things, Mr. Sinha will receive an annual base salary of $440,000, and will be eligible to participate in the Company’s Management Performance Bonus Plan with a target bonus opportunity of 60% of Mr. Sinha’s annual base salary, based on the attainment of one or more pre-established performance goals.
As a material inducement for Mr. Sinha to accept the terms and conditions of the Offer Letter and enter into an employment relationship with the Company as its CFO, the Offer Letter provides for the grant to Mr. Sinha of the following two equity awards which are intended to be granted under the Company’s 2022 Employment Inducement Incentive Plan effective as of the Start Date: (1) an award of performance stock units with a target grant value of $1,000,000 and which will be eligible to vest based upon (i) the Company achieving annual trailing four (4) quarters’ publicly reported revenue of $200,000,000 or greater at any time on or before December 31, 2030, and, subsequently, (ii) the Company’s common stock achieving a closing share price of $65 or greater, calculated as an average over a trading period of fifteen (15) trading days, at any time on or before December 31, 2031, subject to Mr. Sinha’s continued service through the applicable vesting date (the “2026 PSU”), and (2) an award of Restricted Stock Units with a target grant value of $3,700,000 (the “RSU”) which will vest over four (4) years, with 25% of the shares vesting on the anniversary of the grant date, and the remaining RSUs vesting pro rata by day on the first day of each 12 consecutive quarters thereafter and aligned with fiscal quarterly vesting commencing January 1, 2028.
The Offer Letter also provides for the grant to Mr. Sinha of a performance stock unit award with a target grant value of $1,000,000 that will vest based on performance metrics established under the Company’s Long-Term Incentive Program (“LTIP”) for the performance period beginning January 1, 2027 (the “2027 PSU”). The Company intends to recommend to the Board that the 2027 PSU be granted pursuant to the Company’s 2021 equity incentive plan at the same time as the Company’s 2027 focal grants are awarded to the Company’s executive officers.
The number of shares to be subject to the 2026 and 2027 PSUs and the RSU will be determined by dividing the target grant values of $1,000,000 and $3,700,000, respectively, by the 30-day trailing average of the Company’s common stock price immediately prior to the effective date of grant.
The Offer Letter Provides that Mr. Sinha will be eligible to enter into the Company’s Form of Executive Change in Control Severance Agreement and Form of Indemnification Agreement, copies of which have been included as Exhibit 10.12 and Exhibit 10.14, respectively, to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Mr. Sinha has no family relationship with any director or executive officer of the Company, or any person nominated or chosen by the Company to become a director or executive officer. In addition, he is not party to any transaction required to be disclosed under Item 404(a) of Regulation S-K.
The foregoing description of Mr. Sinha’s compensation arrangement with the Company is qualified in its entirety to the offer letter filed as Exhibit 10.1 to this Report, and incorporated by reference herein.
2
| Item 7.01. | Regulation FD Disclosure |
On August 6, 2026, the Company issued a press release announcing the leadership change described above. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Section 7.01 by reference.
The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
The following exhibit is filed herewith and this list is intended to constitute the exhibit index.
| Exhibit Number |
Description | |
| 10.1 | Offer Letter between Arteris, Inc. and Saurabh Sinha, dated July 16, 2026 | |
| 99.1 | Press Release dated August 6, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 6, 2026
| By: | /s/ K. Charles Janac | |
| Name: | K. Charles Janac | |
| Title: | Chief Executive Officer |
4
Exhibit 99.1
Arteris Appoints Saurabh Sinha as Chief Financial Officer
CAMPBELL, Calif., – August 6, 2026 – Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced the appointment of Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. Mr. Sinha succeeds Nick Hawkins, who is retiring after seven years with the company. Mr. Hawkins will provide continued support in an advisory role to facilitate a seamless transition.
“Arteris is executing on a significant growth opportunity as AI and semiconductor innovation drive increasing demand for sophisticated data movement system IP,” said K. Charles Janac, president and CEO of Arteris. “Saurabh is a seasoned public company CFO with a track record of helping technology companies scale. His experience in operational excellence, public company leadership, investor relations and capital markets will be invaluable as we execute our long-term strategy. We wholeheartedly welcome Saurabh to the Arteris management team.”
Janac continued, “I want to thank Nick Hawkins for his leadership and significant contributions to Arteris during his tenure. Nick helped lead Arteris through its successful IPO and built an exceptional finance organization. We wish Nick the best in his next chapter.”
“I am honored to join Arteris at such an exciting point in the company’s evolution,” said Saurabh Sinha. “Arteris has built an exceptional reputation as the trusted system IP partner for many of the world’s leading semiconductor innovators. As AI and other advances in semiconductor architecture continue to reshape computing and emerging application opportunities, the company’s technology, customer relationships and innovation-driven culture position it exceptionally well for continued growth. I’m excited to join the talented Arteris team to build on its success, generating long-term value for its customers, employees and shareholders.”
Mr. Sinha brings more than 25 years of financial leadership experience across public technology companies and high-growth private technology businesses, helping organizations scale operations, strengthen governance and create long-term shareholder value. Since September 2020, he has served as Chief Financial Officer of Aeva Technologies, where he led the company’s finance organization through its transition to the public markets and helped build the infrastructure to support its next phase of growth. Previously, he held senior financial leadership roles at a number of companies including InvenSense, Symmetricom, ShoreTel and JUUL.
Mr. Sinha holds a Bachelor of Commerce degree from the University of Delhi and an MBA from The Wharton School of the University of Pennsylvania.
About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world’s top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.
© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.
Media Contact:
Arteris
Gina Jacobs
+1.408.560.3044
newsroom@arteris.com
Investor Contact:
Sapphire Investor Relations, LLC
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements regarding the expected contributions of Mr. Sinha as Chief Financial Officer, the planned leadership transition, Mr. Hawkins’ continued service as executive advisor through February 2027, the Company’s growth strategy, operational execution, market opportunities, and long-term shareholder value. The words such as “may,” “will,” “could,” “expect,” “approximately,” “believe,” “estimate,” “future,” “guidance,” “outlook,” and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on current expectations, estimates, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from our current expectations. Factors that could cause actual results to differ materially include, among others, the Company’s ability to successfully execute its business strategy, retain and integrate key personnel, respond to changing market conditions, achieve expected operating results, and the other risks described in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Arteris undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law.
#